{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T09:45:07Z","timestamp":1788860707182,"version":"build-2803163510"},"reference-count":23,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.3201\/eid2503.181596","type":"journal-article","created":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T16:47:40Z","timestamp":1549298860000},"page":"523-528","source":"Crossref","is-referenced-by-count":10,"title":["Window Period Prophylaxis for Children Exposed to Tuberculosis, Houston, Texas, USA, 2007\u20132017"],"prefix":"10.3201","volume":"25","author":[{"given":"Andrea T.","family":"Cruz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Starke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2503.181596-201902162220-R1","doi-asserted-by":"publisher","first-page":"317","DOI":"10.15585\/mmwr.mm6711a2","article-title":"Tuberculosis - United States, 2017.","volume":"67","author":"Stewart","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.3201\/eid2503.181596-201902162220-R2","first-page":"392","article-title":"The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era.","volume":"8","author":"Marais","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"key-10.3201\/eid2503.181596-201902162220-R3","unstructured":"American Academy of Pediatrics. Tuberculosis. In: Kimberlin DW, Brady MT, Jackson MA, Long SS, editors. Red Book: 2018 report of the Committee on Infectious Diseases. 31st ed. Itasca (IL): American Academy of Pediatrics; 2018. p. 852."},{"key":"key-10.3201\/eid2503.181596-201902162220-R4","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1056\/NEJMoa1714284","article-title":"Safety and side effects of rifampin versus isoniazid in children.","volume":"379","author":"Diallo","year":"2018","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2503.181596-201902162220-R5","doi-asserted-by":"publisher","first-page":"e20172838","DOI":"10.1542\/peds.2017-2838","article-title":"Completion rate and safety of tuberculosis infection treatment with shorter regimens.","volume":"141","author":"Cruz","year":"2018","journal-title":"Pediatrics"},{"key":"key-10.3201\/eid2503.181596-201902162220-R6","unstructured":"Division of Tuberculosis Elimination, National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention. Reported tuberculosis in the United States, 2016. 2017 [cited 2018 Oct 9]. https:\/\/www.cdc.gov\/tb\/statistics\/reports\/2016\/pdfs\/2016_Surveillance_FullReport.pdf"},{"key":"key-10.3201\/eid2503.181596-201902162220-R7","first-page":"1","article-title":"Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005.","volume":"54","author":"Jensen","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"key-10.3201\/eid2503.181596-201902162220-R8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.5588\/ijtld.12.0641","article-title":"Twice-weekly therapy for children with tuberculosis infection or exposure.","volume":"17","author":"Cruz","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"key-10.3201\/eid2503.181596-201902162220-R9","unstructured":"National Cancer Institute, National Institutes of Health, US Department of Health and Human Services. Common toxicity criteria (CTC) version 2.0. 1999 Apr 30 [cited 2018 Oct 3]. https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/ctcv20_4-30-992.pdf#search=“revised common toxicity criteria&rdquo"},{"key":"key-10.3201\/eid2503.181596-201902162220-R10","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1164\/ajrccm.161.supplement_3.ats600","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement.","volume":"161","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"key-10.3201\/eid2503.181596-201902162220-R11","first-page":"1","article-title":"Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010.","volume":"59","author":"Mazurek","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"key-10.3201\/eid2503.181596-201902162220-R12","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/INF.0b013e3181609a0a","article-title":"Completion of therapy for latent tuberculosis in children of different nationalities.","volume":"27","author":"Powell","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.3201\/eid2503.181596-201902162220-R13","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/INF.0b013e318236984f","article-title":"Increasing adherence for latent tuberculosis infection therapy with health department-administered therapy.","volume":"31","author":"Cruz","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.3201\/eid2503.181596-201902162220-R14","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.5588\/ijtld.10.0558","article-title":"Adherence to isoniazid preventive therapy in children exposed to tuberculosis: a prospective study from Guinea-Bissau.","volume":"15","author":"Gomes","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"key-10.3201\/eid2503.181596-201902162220-R15","doi-asserted-by":"publisher","first-page":"640","DOI":"10.5588\/ijtld.13.0486","article-title":"Predictors of contact tracing completion and outcomes in tuberculosis: a 21-year retrospective cohort study.","volume":"18","author":"Saunders","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"key-10.3201\/eid2503.181596-201902162220-R16","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1183\/09031936.00009114","article-title":"Yield of tuberculosis contact investigations in Amsterdam: opportunities for improvement.","volume":"44","author":"Sloot","year":"2014","journal-title":"Eur Respir J"},{"key":"key-10.3201\/eid2503.181596-201902162220-R17","doi-asserted-by":"publisher","first-page":"S636","DOI":"10.1093\/infdis\/jix361","article-title":"Tuberculosis infectiousness and host susceptibility.","volume":"216","author":"Turner","year":"2017","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2503.181596-201902162220-R18","first-page":"S2213-2600(17)30079-6","article-title":"The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis.","author":"Dheda","year":"2017","journal-title":"Lancet Respir Med"},{"key":"key-10.3201\/eid2503.181596-201902162220-R19","doi-asserted-by":"publisher","first-page":"972","DOI":"10.5588\/ijtld.18.0173","article-title":"Droplets, dust and guinea pigs: an historical review of tuberculosis transmission research, 1878-1940.","volume":"22","author":"Donald","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"key":"key-10.3201\/eid2503.181596-201902162220-R20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.5588\/ijtld.11.0393","article-title":"Tuberculosis contact investigation in a high-burden setting: house or household?","volume":"16","author":"Van Wyk","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"key-10.3201\/eid2503.181596-201902162220-R21","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.5588\/ijtld.12.0027","article-title":"Well-quantified tuberculosis exposure is a reliable surrogate measure of tuberculosis infection.","volume":"16","author":"Mandalakas","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"key-10.3201\/eid2503.181596-201902162220-R22","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.3201\/eid2410.180459","article-title":"Tuberculosis treatment monitoring by video directly observed therapy in 5 health districts, California, USA.","volume":"24","author":"Garfein","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2503.181596-201902162220-R23","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1001\/jamapediatrics.2014.3158","article-title":"Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid.","volume":"169","author":"Villarino","year":"2015","journal-title":"JAMA Pediatr"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/25\/3\/18-1596_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T17:27:57Z","timestamp":1732987677000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/25\/3\/18-1596_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2503.181596","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}